In the BioHarmony Drug Report Database

"Preview" Icon

Neomycin

Mycifradin (neomycin) is a small molecule pharmaceutical. Neomycin was first approved as Mycifradin on 1982-01-01. It is used to treat bacterial infections, bacterial skin diseases, escherichia coli infections, and hepatic encephalopathy in the USA. It is known to target extracellular calcium-sensing receptor.

 

Trade Name

 

Mycifradin
 

Common Name

 

neomycin
 

ChEMBL ID

 

CHEMBL3989751
 

Indication

 

bacterial infections, bacterial skin diseases, escherichia coli infections, hepatic encephalopathy
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Neomycin structure rendering